Brief: Perspective Therapeutics’ VMT-Α-NET Protocols Presented At The North American Neuroendocrine Tumor Society (Nanets) 2023 Symposium
10/10/2023 13:10
Oct 10 (Reuters) - Perspective Therapeutics Inc
CATX.A :
* PERSPECTIVE THERAPEUTICS’ VMT-Α-NET PROTOCOLS PRESENTED AT
THE
NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY (NANETS) 2023
SYMPOSIUM
Source text for Eikon: ID:nGNX6R67lX
Further company coverage: CATX.A
((Reuters.Briefs@thomsonreuters.com))
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise